Efficacy of Tunlametinib in Combination With Anti-EGFR Monoclonal Antibody in Patients With RAS-Mutated Advanced Gastrointestinal Malignancies
Clinical trial NCT07446270 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07446270
- Sponsor
- Chinese PLA General Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-03
- Primary completion
- 2027-10-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.